Chidamide Plus DCAG for Relapsed/Refractory AML
Clinical trial NCT02886559 · UNKNOWN
Trial details
- NCT number
- NCT02886559
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2018-06-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.